Quick Facts
Founded
2012 (14 years)
Headquarters
Irvine, United States
Total Funding
$300M
Stock
AXNX (Public)
Type
commercial
Primary Focus
medical robotics
About Axonics
Axonics develops the Axonics Sacral Neuromodulation System, an implantable device treating overactive bladder, bowel incontinence, and urinary retention. Notably, their long-lasting therapy boasts 93% patient response after 2 years and high satisfaction rates. Recently acquired by Boston Scientific for an undisclosed amount, Axonics previously secured $300M in funding and holds a specialized position in the sacral neuromodulation market. The company focuses on providing a discreet and clinically proven alternative to traditional therapies.
Key Products & Services
Axonics Sacral Neuromodulation System
Industry Sectors
Quick Links
Company Details
- Country
- United States
- City
- Irvine
- State
- California
- Type
- commercial
- Stock
- AXNX
Location
Open in Google MapsSee incorrect or outdated information? Suggest an edit →
Similar Companies
Companies with similar characteristics to Axonics
Kurion
Irvine, United States
Same country Same city Same category
Neocis
Miami, United States
Same country Same category
$75M+ raised
Asensus Surgical
Durham, United States
Same country Similar funding Same category
$300M+ raised
Auris Health
Redwood City, United States
Same country Similar funding Same category
$500M+ raised
Capstan Medical
Santa Cruz, United States
Same country Similar funding Same category
$150M+ raised
Medrobotics
Raynham, United States
Same country Similar funding Same category
$200M+ raised